The Anecdotal History of Screening for Congenital Hypothyroidism
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
THIS YEAR marks the 25th anniversary of the establishment of the first screening program for congenital hypothyroidism in April 1974 in Quebec. Since then, more than 150,000,000 newborns have been tested, thus, around 42,000 detected. It is estimated that one million newborns are tested yearly and 2800 detected. New programs are being established regularly in developing countries, a good example being the Mexican experience (1). The American Office of Technology Assessment (2) concludes that screening for congenital hypothyroidism is one of the few programs in preventive medicine that has an impact on public health with a positive cost to benefit ratio (10:1). This is the anecdotal history of screening for congenital hypothyroidism for this special issue of the journal. My interest in fetal and neonatal thyroid physiology and pathology originated with my first research project as a fellow of the Canadian Medical Research Council with Dr. Robert Volpe at the University of Toronto in late 1960. We studied the placental transfert of T3 in the human (3). To pursue further our investigation on the subject, we moved to Dr. D.A. Fisher’s laboratory at UCLA Harbor General Campus using the sheep as a model (3). At the same time and place, our friend and colleague, Inder J. Chopra, was developing RIA for T3 and T4 (4). On our departure to Quebec in 1971, we were given antibodies for both these hormones and TSH. During the same period, Raiti and Newns (5) and Klein et al. (6) published data showing that if congenital hypothyroidism was treated early (within 3 months after birth) those infants developed normally intellectually. On the other hand, Jacobsen and Brandt (7) later determined that only one third of the newborns were diagnosed during that period. Klein et al. (8) showed that serum measurements of thyroid hormones (T4-TSH) in cord blood could detect hypothyroidism in the neonatal period. Because we had a disease that was difficult to diagnose clinically with deleterious effect on mental development but reversible if treated early, a treatment, synthetic L-thyroxine, thus an ideal disease for mass screening if a method for detection was available. On our arrival at the Centre Hospitalier de l’Université Laval in Quebec city, the laboratory space allotted to us was situated near the provincial laboratory of the Quebec Network for Genetic Medicine, which was screening for phenylketonuria and tyrosinemia using filter paper blood samples. Why not T4! We, thus, developed a RIA for the measurement of T4 from the eluate of filter paper blood spots in late 1971 and early 1972. Our abstract was not accepted by The Endocrine Society for the 1972 International Meeting and was first presented at a Quebec Clinical Investigation Society in September 1972 (9) and at a national meeting of the Canadian Society for Clinical Investigation in January 1973 (10). That same year, supported by the Quebec Network for Genetic Medicine, we did a pilot study on 30,000 samples and detected four cases of congenital hypothyroidism. Our preliminary report on mass screening for congenital hypothyroidism was not accepted for publication by Clinical Chemistry or The New England Journal of Medicine, which judged the report irrelevant! A year later they published an editorial on the importance of the subject (11). Thus, our first report was published in French in 1973 (12). In April 1974, mass screening for congenital hypothyroidism was incorporated with phenylketonuria and tyrosinemia and available to every newborn of the Province of Quebec. In the fall our preliminary report was presented at The American Thyroid Association, but as the last paper of the last session of the meeting (13)! Very rapidly the screening laboratory was computerized by Jean Morissette and we developed a tight relationship with two pediatric endocrinologists, Jacques Letarte at Ste. Justine and Harvey Guyda at the Montreal Children’s Hospital. Detected cases were referred to those two centers and in Quebec City. The four of us met frequently to establish treatment protocols, clinical examination techniques that lead to a hypothyroid clinical index, confirmation procedures for the diagnosis (serum levels of TSH-T4), thyroid scan, bone age, and follow-up. After our publication in the Journal of Pediatrics (14) we received numerous inquiries on the subject, and other programs were established, particularly in New England, Oregon, and France. Concomitantly we developed a TSH (15) and T4-binding globulin (16) assay for filter paper blood to minimize the number of false positive results. The first controversy to arise on screening for congenital hypothyroidism was about the sample collection, cord blood, or serum (17) vs. filter paper heel blood taken between 3 and 5 days of age. The argument was quickly resolved because all the programs piggy-backed T4 determination done on filter paper for logistical and economical reasons. The second controversy, and still alive, was on the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
A Radioimmunoassay for Measurement of Thyroxine in Unextracted Serum*
CHOPRA, I. J. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-6-938 · Cited by 539
Improved prognosis in congenital bypothyroidism treated before age three months
Klein, A. H., Meltzer, S., & Kenny, F. M. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80542-0 · Cited by 323
Tillotson, S. L., Fuggle, P. W., Smith, I., Ades, A. E., & Grant, D. B. (1994) · BMJ · doi:10.1136/bmj.309.6952.440 · Cited by 177
Cited by
Corbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247
Deladoëy, J., Ruel, J., Giguère, Y., & Van Vliet, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1073 · Cited by 235
Neonatal Detection of Congenital Hypothyroidism of Central Origin
van Tijn, D. A., de Vijlder, J. J. M., Verbeeten, B., Verkerk, P. H., & Vulsma, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2444 · Cited by 139
Neonatal screening for congenital adrenal hyperplasia
van der Kamp, H., & Wit, J. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u071 · Cited by 128
Lanting, C. I., van Tijn, D. A., Loeber, J. G., Vulsma, T., de Vijlder, J. J. M., & Verkerk, P. H. (2005) · Pediatrics · doi:10.1542/peds.2004-2162 · Cited by 97
Metadata
- Authors
- Dussault, J. H.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 84
- Issue
- 12
- Pages
- 4332-4334
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2105967379
- Cited by
- 92
- References
- 4
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.